JTO Clinical and Research Reports
Издатель: Elsevier · ISSN 2666-3643 · 50 статей
- READY Lung: A Community-Engaged Educational Intervention to Improve Lung Cancer Screening and Treatment Knowledge in Black Communities
- Radiological Surveillance Strategies After Curative Resection of Lung Cancer: A Systematic Review and Meta-Analysis
- Intracranial Activity of Tarlatamab and Outcomes of Continued Treatment with Local Therapy in Patients with Brain Metastases from Small Cell Lung Cancer: A Brief Report
- Five-year longitudinal impact of surgical approach, extent of resection, and tumor stage on health-related quality of life and pain after lung cancer surgery
- Outcomes After Lung Cancer Screening: An Analysis of the Linked American College of Radiology Lung Cancer Screening Registry, Medicare, and Surveillance, Epidemiology, and End Results (SEER) Cancer Registry Data
- The Human Virome and its Association with Clinical Benefit of Immune Checkpoint Inhibitor Therapy among Advanced Patients with Non-small cell Lung Cancer
- Association of Delayed Adjuvant Targeted Therapy With Recurrence Risk in Resected EGFR-Mutant Non-Small Cell Lung Cancer: A Multicenter Real-World Study
- CNS Efficacy of Osimertinib Plus Savolitinib in Epidermal Growth Factor Receptor-Mutated Advanced Non-Small Cell Lung Cancer With MET Overexpression and/or Amplification: A Brief Report
- Real-World Uptake of First-Line Immunotherapy in Advanced Non-Small Cell Lung Cancer in the US, 2010-2021
- Feasibility and prognostic relevance of maintenance after chemoimmunotherapy in extensive-stage small-cell lung cancer: a real-world study
- CAPZA2::MET Fusion and MET Amplification in EGFR-Mutated Advanced Non–Small Cell Lung Cancer With Marked Response to Capmatinib Monotherapy: A Case Report
- Clinicogenomic profiling of MET-driven non-small cell lung cancer in a nationwide Taiwanese cohort from the TCOG T1521 registry
- Limb Cryocompression and Chemotherapy-Induced Peripheral Neuropathy During Carboplatin–Taxane Immunochemotherapy in Advanced Non-Small Cell Lung Cancer: A Prospective Multicenter Study
- Molecular Profiling Significantly Refines Histologic Classification of Multiple Non-Squamous NSCLCs: Evidence from a Swiss Cohort
- Results From a Multi-Center Survey Among Physicians and Patients on the Acceptance of New Treatment Strategy With Third Generation of EGFR-TKI Plus Bispecific Antibody for Advanced EGFR-Mutant NSCLC
- Osimertinib After Amivantamab-Lazertinib–Associated Pneumonitis in EGFR-Mutant NSCLC: A Two-Case Report
- Defining Effective Margin Distances to Minimize Locoregional Recurrence After Sublobar Resection for ≤2 cm Invasive Lung Adenocarcinoma
- CDKN2A/B Deletions Are Associated With Inferior Outcomes With First-Line Immune Checkpoint Inhibitor-Based Therapy in Advanced Non-small Cell Lung Carcinoma
- Thymic Carcinoma with Treatment-Related Leukemia Showing Complete Response to Bcl-2 Inhibitors and 5-azacytidine: A Case Report
- Impact of CNS radiotherapy on outcomes in metastatic EGFR-mutant non–small cell lung cancer with synchronous brain metastasis
- Brief Report: Clinical use, access, and awareness of the utility of ctDNA-based liquid biopsy for NSCLC among oncologists in Latin America – The OMEGA survey.
- Brief report: Tumor Inflammation-Associated Neurotoxicity (TIAN) in patients with small cell lung cancer treated with tarlatamab
- Brief report: Clinical use of zongertinib in patients with HER2 mutated NSCLC with brain metastases with or without leptomeningeal disease
- Comparison of longitudinal and cumulative toxicity associated with targeted therapy versus chemotherapy for advanced EGFR-mutant NSCLC: post-hoc analysis of LUX-Lung 3
- Unexpected tarlatamab efficacy and toxicity in atypical carcinoid and large cell neuroendocrine carcinoma, and DLL3 level as a potential biomarker
- Real-World DLL3 Expression and Molecular Subtypes in Small Cell Lung Cancer: A French Cohort Study
- Real-World Survival After Neoadjuvant Chemoimmunotherapy for Resectable Non-Small Cell Lung Cancer
- Toward Global Integration of Exercise in Lung Cancer Care: The IREX-Lung Initiative
- Dual Checkpoint Inhibition With or Without Chemotherapy in Metastatic NSCLC: A Reconstructed Individual Patient Data Meta-Analysis
- Lung-Reporting and Data System Category (Lung-RADS) and Adherence to Low-Dose Computed Tomography Screening and Recommended Follow-Up: A Multicenter Cohort Study